Our company aims to save human lives
by developing and popularizing a pre-surgical simulator to increase surgical success rates for those with heart disease, and we take our mission incredibly seriously.
This project was started together with Dr. Shiraishi at the National Cerebral and Cardiovascular Center in 2009.
We started with the hope that we can use our cultivated technology to help the
1 in 100 people who have a congenital heart disease.
Moving forward, we will continue to work hard to support the various demands of the medical field,
providing soft heart models that have a high degree of reproducibility for surgeons throughout the world.
CEO Masatoshi Takeda